Serviceeinschränkungen vom 12.-22.02.2026 - weitere Infos auf der UB-Homepage
American Psychological Association 6th edition

Marchiset-Leca D, Leca FR, Galeani A, Noble A, & Iliadis A. (1995). A limited sampling strategy for the study of pirarubicin pharmacokinetics in humans. Cancer Chemotherapy and Pharmacology, 36(3), 233-233. https://doi.org/10.1007/BF00685852

ISO-690 (author-date, English)

MARCHISET-LECA D, LECA FR, GALEANI A, NOBLE A und ILIADIS A, 1995. A limited sampling strategy for the study of pirarubicin pharmacokinetics in humans. Cancer chemotherapy and pharmacology. 1 Januar 1995. Vol. 36, no. 3, p. 233-233. DOI 10.1007/BF00685852.

Modern Language Association 9th edition

Marchiset-Leca D, Leca FR, Galeani A, Noble A, und Iliadis A. „A Limited Sampling Strategy for the Study of Pirarubicin Pharmacokinetics in Humans.“. Cancer Chemotherapy and Pharmacology, Bd. 36, Nr. 3, Januar 1995, S. 233-, https://doi.org/10.1007/BF00685852.

Mohr Siebeck - Recht (Deutsch - Österreich)

Marchiset-Leca D/Leca FR/Galeani A/Noble A/Iliadis A: A limited sampling strategy for the study of pirarubicin pharmacokinetics in humans., Cancer chemotherapy and pharmacology 1995, 233-233.

Emerald - Harvard

Marchiset-Leca D, Leca FR, Galeani A, Noble A und Iliadis A. (1995), „A limited sampling strategy for the study of pirarubicin pharmacokinetics in humans.“, Cancer Chemotherapy and Pharmacology, Vol. 36 No. 3, S. 233-233.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.